Hims & Hers Health (HIMS) Ratios
Hims & Hers Health Ratios
MX:HIMS's free cash flow for Q2 2026 was $-55.38M. For the 2026 fiscal year, MX:HIMS's free cash flow was decreased by $-19.45M and operating cash flow was $-35.94M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.90 | 1.79 | 3.00 | 4.52 | 3.41 |
| Quick Ratio | 1.61 | 1.50 | 2.74 | 4.07 | 3.24 |
| Cash Ratio | 0.57 | 1.00 | 1.09 | 0.98 | 0.91 |
| Solvency Ratio | 0.11 | 0.62 | -0.14 | -1.07 | -1.20 |
| Operating Cash Flow Ratio | 0.74 | 1.13 | 0.83 | -0.55 | -0.43 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -846.14M | $ 165.01M | $ 167.90M | $ 162.00M | $ 183.94M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.52 | 0.02 | 0.02 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 2.07 | 0.02 | 0.03 | 0.02 | 0.02 |
| Debt-to-Capital Ratio | 0.67 | 0.02 | 0.03 | 0.02 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.64 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 3.98 | 1.48 | 1.28 | 1.18 | 1.26 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 4.98 | 0.05 | 0.05 | 0.03 | 0.03 |
| Net Debt to EBITDA | 5.00 | -2.36 | 4.35 | 0.68 | 0.60 |
| Profitability Margins | |||||
| Gross Profit Margin | 73.84% | 79.45% | 81.99% | 77.57% | 75.22% |
| EBIT Margin | 5.28% | 4.86% | -3.38% | -13.04% | -42.31% |
| EBITDA Margin | 7.60% | 6.01% | -2.29% | -11.62% | -40.81% |
| Operating Profit Margin | 4.50% | 4.19% | -3.38% | -13.04% | -42.31% |
| Pretax Profit Margin | 5.28% | 4.86% | -2.47% | -12.47% | -40.75% |
| Net Profit Margin | 5.47% | 8.54% | -2.70% | -12.46% | -39.60% |
| Continuous Operations Profit Margin | 5.47% | 8.54% | -2.70% | -12.46% | -39.60% |
| Net Income Per EBT | 103.58% | 175.76% | 109.16% | 99.95% | 97.17% |
| EBT Per EBIT | 117.34% | 115.84% | 73.24% | 95.65% | 96.31% |
| Return on Assets (ROA) | 5.96% | 17.81% | -5.34% | -17.93% | -25.60% |
| Return on Equity (ROE) | 23.73% | 26.44% | -6.84% | -21.07% | -32.17% |
| Return on Capital Employed (ROCE) | 6.03% | 12.73% | -8.35% | -21.58% | -33.70% |
| Return on Invested Capital (ROIC) | 6.02% | 12.68% | -8.32% | -21.45% | -32.62% |
| Return on Tangible Assets | 7.64% | 22.86% | -7.55% | -28.11% | -37.93% |
| Earnings Yield | 1.76% | 2.41% | -1.26% | -5.01% | -8.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 73.02 | 242.85 | 129.22 | 163.08 | 76.01 |
| Payables Turnover | 4.29 | 3.33 | 3.65 | 3.65 | 3.43 |
| Inventory Turnover | 5.31 | 4.71 | 6.99 | 5.48 | 4.97 |
| Fixed Asset Turnover | 5.23 | 15.88 | 19.07 | 32.66 | 53.19 |
| Asset Turnover | 1.09 | 2.09 | 1.98 | 1.44 | 0.65 |
| Working Capital Turnover Ratio | 8.73 | 8.41 | 5.05 | 2.93 | 1.88 |
| Cash Conversion Cycle | -11.37 | -30.68 | -45.07 | -31.12 | -28.14 |
| Days of Sales Outstanding | 5.00 | 1.50 | 2.82 | 2.24 | 4.80 |
| Days of Inventory Outstanding | 68.77 | 77.51 | 52.21 | 66.59 | 73.44 |
| Days of Payables Outstanding | 85.14 | 109.70 | 100.10 | 99.94 | 106.38 |
| Operating Cycle | 73.77 | 79.02 | 55.03 | 68.82 | 78.24 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.33 | 1.16 | 0.35 | -0.13 | -0.18 |
| Free Cash Flow Per Share | 0.33 | 0.92 | 0.22 | -0.17 | -0.21 |
| Dividend Paid and CapEx Coverage Ratio | 1.33 | 4.76 | 2.77 | -3.66 | -6.87 |
| Capital Expenditure Coverage Ratio | 1.33 | 4.76 | 2.77 | -3.66 | -6.87 |
| Operating Cash Flow Coverage Ratio | 0.27 | 22.13 | 7.39 | -5.00 | -6.28 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.17 | 0.08 | -0.05 | -0.13 |
| Free Cash Flow Yield | 1.01% | 3.80% | 2.52% | -2.58% | -3.22% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 56.96 | 41.69 | -79.13 | -19.96 | -11.36 |
| Price-to-Sales (P/S) Ratio | 3.11 | 3.54 | 2.14 | 2.49 | 4.50 |
| Price-to-Book (P/B) Ratio | 13.50 | 10.95 | 5.42 | 4.21 | 3.66 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 98.76 | 26.33 | 39.65 | -38.81 | -31.04 |
| Price-to-Operating Cash Flow Ratio | 24.35 | 20.80 | 25.36 | -49.41 | -35.55 |
| Price-to-Earnings Growth (PEG) Ratio | -33.04 | -0.07 | 1.21 | 0.45 | -0.83 |
| Enterprise Value Multiple | 45.94 | 56.44 | -89.10 | -20.74 | -10.43 |
| Enterprise Value | 8.20B | 5.01B | 1.78B | 1.27B | 1.16B |
| EV to EBITDA | 45.94 | 56.44 | -89.10 | -20.74 | -10.43 |
| EV to Sales | 3.49 | 3.39 | 2.04 | 2.41 | 4.26 |
| EV to Free Cash Flow | 110.82 | 25.27 | 37.80 | -37.58 | -29.35 |
| EV to Operating Cash Flow | 27.32 | 19.96 | 24.18 | -47.85 | -33.63 |
| Tangible Book Value Per Share | 0.30 | 1.48 | 1.02 | 0.88 | 1.06 |
| Shareholders’ Equity Per Share | 2.40 | 2.21 | 1.64 | 1.52 | 1.79 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.04 | -0.76 | -0.09 | 0.00 | 0.03 |
| Revenue Per Share | 10.44 | 6.84 | 4.17 | 2.58 | 1.46 |
| Net Income Per Share | 0.57 | 0.58 | -0.11 | -0.32 | -0.58 |
| Tax Burden | 1.04 | 1.76 | 1.09 | 1.00 | 0.97 |
| Interest Burden | 1.00 | 1.00 | 0.73 | 0.96 | 0.96 |
| Research & Development to Revenue | 0.06 | 0.05 | 0.06 | 0.06 | 0.08 |
| SG&A to Revenue | 0.51 | 0.57 | 0.15 | 0.19 | 0.42 |
| Stock-Based Compensation to Revenue | 0.06 | 0.06 | 0.08 | 0.08 | 0.25 |
| Income Quality | 2.34 | 1.99 | -3.12 | 0.40 | 0.32 |
Currency in USD
